These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 9218725)

  • 41. Surveillance of Dutch Patients With Li-Fraumeni Syndrome: The LiFe-Guard Study.
    Ruijs MWG; Loo CE; van Buchem CAJM; Bleiker EMA; Sonke GS
    JAMA Oncol; 2017 Dec; 3(12):1733-1734. PubMed ID: 28772294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
    Villani A; Shore A; Wasserman JD; Stephens D; Kim RH; Druker H; Gallinger B; Naumer A; Kohlmann W; Novokmet A; Tabori U; Tijerin M; Greer ML; Finlay JL; Schiffman JD; Malkin D
    Lancet Oncol; 2016 Sep; 17(9):1295-305. PubMed ID: 27501770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pilot study of the prevalence of autoimmune disorders in Li-Fraumeni syndrome.
    Obregón IH; de Andrade KC; Bremer RC; Khincha PP; Savage SA
    Fam Cancer; 2023 Jul; 22(3):319-321. PubMed ID: 36627407
    [No Abstract]   [Full Text] [Related]  

  • 44. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
    Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Li-Fraumeni syndrome.
    Ponz de Leon M
    Recent Results Cancer Res; 1994; 136():275-86. PubMed ID: 7863100
    [No Abstract]   [Full Text] [Related]  

  • 46. [Li-Fraumeni syndrome].
    Tokunaga A; Onda M; Matsukura N; Kato S
    Nihon Rinsho; 1995 Nov; 53(11):2797-802. PubMed ID: 8538047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome.
    Hatton JN; Sargen MR; Frone MN; de Andrade KC; Savage SA; Khincha PP
    J Invest Dermatol; 2022 Sep; 142(9):2534-2537.e1. PubMed ID: 35183552
    [No Abstract]   [Full Text] [Related]  

  • 48. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
    Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.
    Villani A; Tabori U; Schiffman J; Shlien A; Beyene J; Druker H; Novokmet A; Finlay J; Malkin D
    Lancet Oncol; 2011 Jun; 12(6):559-67. PubMed ID: 21601526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum: Preliminary Data of the LIFSCREEN Randomized Clinical Trial.
    Caron O; Frebourg T; Benusiglio PR; Foulon S; Brugières L
    JAMA Oncol; 2017 Dec; 3(12):1736-1737. PubMed ID: 28772306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Willingness of individuals with Li-Fraumeni syndrome to participate in a cancer prevention trial: a survey study.
    Struewe FJ; Schott S; de Zwaan M; Kratz CP
    Fam Cancer; 2023 Oct; 22(4):495-497. PubMed ID: 37351819
    [No Abstract]   [Full Text] [Related]  

  • 52. Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family.
    Schiffman JD; Chun N; Fisher PG; Dahl GV; Ford JM; Eggerding FA
    Pediatr Blood Cancer; 2008 Apr; 50(4):914-6. PubMed ID: 17554785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel p.Gly187Arg TP53 variant appears to result in Li-Fraumeni syndrome.
    Doyle MR; Johnston JM
    Pediatr Hematol Oncol; 2018 Apr; 35(3):203-207. PubMed ID: 30239254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential of Advexin: a p53 gene-replacement therapy in Li-Fraumeni syndrome.
    Nemunaitis JM; Nemunaitis J
    Future Oncol; 2008 Dec; 4(6):759-68. PubMed ID: 19086841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.
    Bojadzieva J; Amini B; Day SF; Jackson TL; Thomas PS; Willis BJ; Throckmorton WR; Daw NC; Bevers TB; Strong LC
    Fam Cancer; 2018 Apr; 17(2):287-294. PubMed ID: 28988289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Li-Fraumeni syndrome: an inherited susceptibility to cancer.
    Evans SC; Lozano G
    Mol Med Today; 1997 Sep; 3(9):390-5. PubMed ID: 9302689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
    Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of Association Between oral Squamous cell Carcinoma and Li-Fraumeni Syndrome.
    Dos Santos ES; Santos-Silva AR
    Head Neck Pathol; 2023 Mar; 17(1):277-278. PubMed ID: 36344907
    [No Abstract]   [Full Text] [Related]  

  • 59. Genetic counseling can influence the course of a suspected familial cancer syndrome patient: from a case of Li-Fraumeni like syndrome with a germline mutation in the TP53 gene.
    Hwang SM; Lee ES; Shin SH; Kong SY
    Korean J Lab Med; 2008 Dec; 28(6):493-7. PubMed ID: 19127115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case Report of an Unusual Tumor in an Adult With a TP53 Germline Mutation.
    Castiaux J; Vandernoot I; Dallemagne J; Bruneau M; Delaunoy M; Peyrassol X; Heimann P; De Wilde V; Wolfromm A
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e645-e648. PubMed ID: 34049842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.